Home / Resources / Case Studies

案例研究

Featured case study

重塑医药未来：Biohaven 公司 Nurtec™ 药物的研发之旅

In February 2020, Biohaven Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved Nurtec™ (Rimegepant) for the acute treatment of migraines in…

Latest case studies

All Case Study

How Model-informed drug development rescue projects from a risky situation

Discover how Certara’s integrated approach to model-informed drug development helps clients navigate…

通过 PBPK 模型推动儿童癫痫个性化治疗

GRIN Therapeutics, Inc., an affiliate of Neurvati Neurosciences, focuses on the research…

Delivering DSUR Excellence for Multinational Biopharma

A global leader in immuno-oncology approached us for support with over 50…

Popular case studies

All Case Study

Certara MIDD 专家如何克服客户的监管挑战

罕见病真实世界数据标准化：ATHN 之旅

利用 Phoenix Hosted 实现成功：真实世界的客户案例

QSP 建模优化多发性骨髓瘤疗法的首次人体试验剂量选择

Quantitative systems pharmacology model of mRNA lipid nanoparticle for two programs at the preclinical to clinical transition

帮助申办方满足 EMA Policy 0070 要求

All case studies

Quantitative systems pharmacology model of mRNA lipid nanoparticle for two programs at the preclinical to clinical transition

Modeling and Simulation - QSP, Case Study

帮助申办方满足 EMA Policy 0070 要求

Clinical Transparency & Disclosure, Regulatory, Case Study

简化 1 年期和 2 年期 PSUR 的准备工作

Regulatory, Case Study

及时对 EMA 安全性问题做出高质量回应

Certara Services, Regulatory, Case Study

CMC 写作支持帮助客户解除临床搁置状态

Regulatory, Case Study

1
2
3
……
7
›

Be the first to get the latest

Transforming drug development is not just our goal—it’s our obsession. 如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

案例研究

Featured case study

重塑医药未来：Biohaven 公司 Nurtec™ 药物的研发之旅

Latest case studies